Skip to main content

Circulomics Awarded Phase I SBIR to Develop Nanobind DNA Extraction Technology

By May 1, 2014News
ciculomic-logo

ciculomic-logo

Circulomics Inc has been awarded a Phase I Small Business Innovative Research (SBIR) grant by the National Institutes of Health (NIH) to develop its new Nanobind DNA/RNA extraction technology. 

Nanobind is an inexpensive thermoplastic nanomaterial developed for high integrity DNA and RNA extraction. Its hierarchical structure of microscale folds topped by nanoscale wrinkles creates a high binding area silica surface capable of capturing large amounts of high molecular weight (MW) DNA and RNA.

{iframe}http://www.marketwired.com/press-release/circulomics-awarded-phase-i-sbir-to-develop-nanobind-dna-extraction-technology-1904758.htm{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.